Perivascular versus nonperivascular hepatocellular carcinoma treated with liver resection: a retrospective propensity score matching comparison of long-term outcomes

采用肝切除术治疗血管周围型与非血管周围型肝细胞癌:回顾性倾向评分匹配比较长期疗效

阅读:1

Abstract

BACKGROUND: The outcomes for perivascular hepatocellular carcinoma (HCC) and nonperivascular HCC after hepatectomy have not been well illustrated. This study aimed to compare long-term outcomes between perivascular and nonperivascular HCC. METHODS: A total of 714 HCC patients were retrospectively collected and categorized into perivascular and nonperivascular groups according to whether the tumors had contact with branches of the portal or hepatic vein. A 1:1 propensity score matching (PSM) with a caliper of 0.02 was used to eliminate bias. Disease-free survival (DFS) and overall survival (OS) were assessed using the Kaplan-Meier method, and long-term survival analyses were conducted. RESULTS: After PSM, 249 pairs of patients were enrolled in a nonadjacent portal vein (nPV) group and an adjacent portal vein (aPV) group. Additionally, 268 pairs of patients were enrolled in a nonadjacent hepatic vein (nHV) group and an adjacent hepatic vein (aHV) group. The aPV group had significantly worse DFS than the nPV group (5-year recurrence rates: 69.3% vs. 58.5%; P=0.008) and OS (5-year mortality: 48.6% vs. 39.0%; P=0.023). In contrast, no significant survival differences were observed between the aHV and nHV groups (DFS: P=0.980; OS: P=0.810). Multivariate analysis indicated that the tumor being adjacent to the portal vein was an independent risk factor for tumor recurrence [hazard ratio (HR) =1.374; 95% confidence interval (CI): 1.091-1.730] and overall mortality (HR =1.434; 95% CI: 1.086-1.893). CONCLUSIONS: HCC adjacent to the portal vein negatively impacted the prognosis, whereas the hepatic vein did not appear to have such an influence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。